Nucleoside reverse transcriptase inhibitors (NRTIs)

M161 M161 Pill - yellow capsule-shape, 21mm

Pill with imprint M161 M161 is Yellow, Capsule-shape and has been identified as Didanosine Delayed Release 250 mg. It is supplied by Mylan Pharmaceuticals Inc.

Didanosine is used in the treatment of Nonoccupational Exposure; HIV Infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Didanosine (Didanosine [ dye-dan-oh-seen ])-M161 M161-250 mg-Yellow-Capsule-shape

Didanosine
Generic Name: didanosine [ dye-dan-oh-seen ]
Imprint: M161 M161
Strength: 250 mg
Color: Yellow
Size: 21.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00378-8888 (Discontinued)
Inactive Ingredients: Ferrosoferric oxide, Carboxymethylcellulose sodium, Silicon dioxide, Diethyl phthalate, Gelatin, Hypromelloses, Methacrylic acid - methyl methacrylate copolymer (1:1), Propylene glycol, Ferric oxide red, Shellac, Trisodium citrate dihydrate, Sodium lauryl sulfate, Sodium starch glycolate type A potato, Magnesium silicate, Titanium dioxide, Ferric oxide yellow, Potassium hydroxide, Ammonia,
Latest News
Related Drugs